Results

Total Results: 1,767 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare-admin.ahrq.gov/products/alcohol-use-disorders/research
    May 01, 2024 - (ACA) vs. 6 events (placebo) 7 events (ACA) vs. 6 events (placebo) insufficient SOE 8/2677 NA insufficient … Adverse effects KQ 3a. … What adverse effects are associated with medications for adults with alcohol use disorder in outpatient … How do medications for adults with alcohol use disorder compare for adverse effects in outpatient settings … Trials of topiramate have reported a significantly increased risk of many adverse events, including difficulty
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
    August 05, 2010 - • Adverse events will be evaluated from studies of the drugs used for osteoarthritis, rheumatoid … Also, adverse events may occur at any point after the treatment is received. IV. Methods A. … We assumed that the adverse events occurred independently and that the logarithm of the rate ratios … After estimating the effect (number of events prevented or caused) for each of the three adverse events … We also pooled clinical success rates and withdrawal due to adverse events from head- to-head trials
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2024-surv-rep-update-table-appendix-e.xlsx
    January 01, 2024 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse eventsadverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverseevents: 4.65% (10/215) vs.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
    January 01, 2024 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse eventsadverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverseevents: 4.65% (10/215) vs.
  5. effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-update/research-protocol
    December 01, 2019 - Outcomes include intermediate outcomes, long-term outcomes, safety, adverse events, mortality, and quality … Adverse events include congestive heart failure, hypoglycemia, pancreatitis, fractures, and cancer. … events. … Outcomes include intermediate outcomes, long-term outcomes, safety, adverse events, mortality, and quality … Adverse events include congestive heart failure, hypoglycemia, pancreatitis, fractures, and cancer.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - adverse events according to drug class? … Harms and Adverse Events a. … adverse events according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events,
  7. effectivehealthcare-admin.ahrq.gov/products/alzheimers-type-dementia/research
    October 01, 2022 - ChI) were slightly better than placebo for cognition and function, but increased withdrawals due to adverse … produced small improvements in cognition and function compared with placebo but may increase serious adverseevents and withdrawals due to adverse events.
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - Does the use of procalcitonin guidance reduce antibiotic resistance and antibiotic adverse events? … events of testing (pain, local bleeding, or infection) Adverse events of therapy (persistent … Does the use of procalcitonin guidance reduce antibiotic resistance and antibiotic adverse events? … events of testing (pain, local bleeding, or infection) Adverse events of therapy (persistent … These should include fewer antibiotic adverse events and emergence of drug-resistant pathogens.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
    January 01, 2023 - events or errors resulting from exposure to the health care delivery system. … drug events related to anticoagulants Hours of service, fatigue, and sleepiness We are embarking … Drug Events Related to Opioids Implementation Guide The Institute for Healthcare Improvement’s guide … events related to RRS are infrequent in both adults and children (insufficient SOE) Barriers, Facilitators … events, reduce caregiver and patient stress, and improve patient/caregiver satisfaction 57 57
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
    October 01, 2023 - A recent large scale chart review study showed preventable adverse events occurring in 6.8 percent of … The missing evidence: a systematic review of patients' experiences of adverse events in health care … Adverse in-hospital events are associated with increased in-hospital mortality and length of stay in … Outcomes of Patient-Engaged Video Surveillance on Falls and Other Adverse Events. … Effectiveness of nonpharmacological interventions to prevent adverse events in the intensive care unit
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - • For Key Question 3, conclusions regarding other adverse events are possibly out of date. … Data related to adverse events is listed in Key Questions 2 and 3. … Metformin was associated with more frequent GI adverse events than were DPP-4 inhibitors. … Adverse events (exenatide vs. placebo) were nausea (12% vs. 2%, p = 0.037), vomiting (8% vs. 0%, p … Slightly higher rates of urinary tract infections and adverse events related to osmotic diuresis and
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - serious adverse events.16-19,38,52 Triple Therapy Regimens With Pegylated Interferon, Ribavirin, … risk of serious adverse events than dual therapy with pegylated interferon alfa-2a plus ribavirin ( … However, serious adverse events were only reported in two trials,18,19 and the rate of serious adverseadverse events with use of protease inhibitors, and the adverse events appear to be self-limited following … There was no difference in risk of withdrawal due to adverse events.
  13. effectivehealthcare-admin.ahrq.gov/products/back-pain-treatment/clinician
    June 01, 2021 - Adverse Effects For nonpharmacological therapies, assessment of harms was suboptimal. … Pharmacological therapies are associated with increased risk of adverse events when compared with placebo … Examples of reported adverse effects included mild bleeding at needling sites with acupuncture, skin … Pharmacological Pharmacological therapies were associated with increased risk of adverse events when … addiction, overdose, and death Nonsteroidal anti-inflammatory drugs Cardiovascular thrombotic events
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
    May 16, 2013 - The overall rates of complications/major adverse events were under 7%.9,10,15,18-20,25. … There is a low level of evidence that adverse events associated with RFA are relatively uncommon. … Most of the studies did not report the time of occurrence of the adverse events. … Major adverse events associated with RFA are relatively uncommon. … of the various adverse events were not always comparable.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Opioids were associated with increased risk of various adverse events, including withdrawal due to adverse … There were no serious adverse events with either TENS or opioids. … Harms and Adverse Events: a. … events, serious adverse events, overdose, substance misuse, substance use disorder related outcomes … Harms and Adverse Events: Key Question 3. Dosing Strategies: Key Question 4.
  16. effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medications/research
    December 01, 2019 - intensive lipid-modifying therapy, what are the comparative long-term benefits and rates of serious adverseevents of coadministration of different lipid-modifying agents (i.e., a statin plus another lipid-modifying … Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events … Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
    September 02, 2013 - The adverse events seen in the intervention groups would likely be lower than in the clinical setting … Thus, the occurrence of adverse events can be suppressed while adherence and benefits are accentuated … Run-in periods may suppress the occurrence of adverse events or accentuate the benefits, or both of these
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
    September 02, 2013 - The adverse events seen in the intervention groups would likely be lower than in the clinical setting … Thus, the occurrence of adverse events can be suppressed while adherence and benefits are accentuated … Run-in periods may suppress the occurrence of adverse events or accentuate the benefits, or both of these
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
    September 14, 2016 - events due to immunotherapy) • Serious adverse events • Anaphylaxis reaction • Hypersensitivity … In addition, adverse events may occur at any point after treatment is received. IV. … Adverse drug reactions: definitions, diagnosis, and management. … events (AE): An injury caused by medical management–rather than by the underlying disease–which prolongs … wound infections, technical complications, negligence, diagnostic mishaps, therapeutic mishaps, and events
  20. effectivehealthcare-admin.ahrq.gov/products/gestational-diabetes-screening-diagnosis/research-protocol
    December 01, 2019 - events. … We will report adverse events as they are reported by the authors of the study. … Examples of adverse events that we have identified a priori are listed in KQ5 above. … with an adverse event. … Hyperglycemia and adverse pregnancy outcome (HAPO) study Cooperative Research Group.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: